Sign in

Phantom limb pain and central post-stroke pain

Neuropathic pain · C8 · Reviewed by a board-certified pain physician on November 2, 2026

Bottom line

Central post-stroke pain is burning or aching pain in the stroke-affected territory, often after thalamic or brainstem lesions, treated like other neuropathic pain; phantom limb pain is common after amputation, and mirror therapy is the most studied nondrug option.

Key points

  1. Central post-stroke pain appears after a latency. It is neuropathic pain in part of the body affected by hemorrhagic or ischemic stroke, usually developing within a few months 1.
  2. Lesion site matters. Thalamic and brainstem lesions are more likely to cause central neuropathic pain than lesions elsewhere 1.
  3. The sensory picture is mixed. Burning, aching or stabbing pain combines hypo- and hypersensitivity; over 90% have thermal, especially cold, sensory abnormalities, while touch and vibration deficits are less common 1.
  4. Treat as central neuropathic pain. Amitriptyline is widely supported as first-line for post-stroke pain, with gabapentinoids, duloxetine and lamotrigine as options; NeuPSIG 2025 lists gabapentinoids, SNRIs and TCAs as first-line for neuropathic pain generally 12.
  5. Phantom limb pain is very common. About 80% of amputees report it in the first year and up to 87% at some point 3.
  6. Mirror therapy is the leading nondrug option. Reflected movement of the intact limb gives the illusion that the missing limb moves; in 32 studies, 21 reported clinically significant reduction, but protocols vary widely. Phantom pain is linked to peripheral and central changes, including cortical reorganization 3.

Watch for

Not all pain after stroke is central: shoulder pain and other post-stroke pains must be distinguished, and the lack of clear diagnostic criteria makes prevalence estimates uncertain 1.

High-yield for the exam

  • Central post-stroke pain affects about 1–12% of stroke patients, reportedly up to 55% 1.
  • Intermittent dysesthesia occurs in up to 85% of central post-stroke pain patients 1.
  • Amitriptyline is typically given at about 75 mg/day for central post-stroke pain 1.
  • In a mixed neuropathic cohort including central post-stroke pain, oral opioids lowered pain by about 23% on average 1.
  • Refractory central post-stroke pain may be considered for deep brain or motor cortex stimulation 1.
  • Mirror therapy versus covered-mirror sham showed no significant difference, suggesting phantom motor execution may be the active component 3.
  • Virtual mirror therapy delivers visual feedback digitally and can track adherence in home programs 3.
  • No unanimous consensus exists on mirror therapy setting, technique, session frequency or duration 3.

Numbers to know

Item Value
CPSP prevalence after stroke 1–12% (up to 55%) 1
CPSP with thermal abnormality >90% 1
Amitriptyline usual dose ~75 mg/day 1
Lamotrigine dose studied in CPSP 200 mg/day 1
Phantom pain in first year ~80% 3
Lifetime phantom pain up to 87% 3
Mirror studies with clinically significant benefit 21 of 32 3

Common traps

  • Treating central post-stroke pain with opioids first; they are not first-line 1.
  • Expecting central post-stroke pain immediately at stroke onset; there is usually a latency, with onset often within a few months 1.
  • Assuming a single standard mirror therapy protocol exists 3.

Practise this topic

7 more questions on this topic in the full question bank, with explanations and sources.

Sources

  1. Asadauskas A, et al. Advancements in modern treatment approaches for central post-stroke pain: a narrative review. J Clin Med, 2024. pmc.ncbi.nlm.nih.gov/articles/PMC11432561/
  2. Soliman N, et al. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. Lancet Neurol, 2025. pubmed.ncbi.nlm.nih.gov/40252663/
  3. Limakatso K, et al. Evaluating mirror therapy protocols in phantom limb pain clinical trials: a scoping review. J Pain Res, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC11812563/

Related topics

Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.